Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Successful inspection by FDA of Penn Pharma’s development and production facility

Penn Pharma
Posted on: 09 Oct 12

Penn Pharma announced today that its Tredegar, South Wales facility has successfully completed a routine FDA inspection. The inspection which covered compliance with cGMP (current Good Manufacturing Practice) also included two PAIs (Pre-Approval Inspections), both of which were also successful.

The inspection, undertaken during August, reviewed selected systems, processes and procedures related to the development, manufacturing and packing of products for the US market and no Form 483 observations were recorded.

Commenting on the inspection, Richard Yarwood, CEO said: “We are extremely pleased with this successful inspection which confirms Penn’s commitment to meeting the highest quality standards. We will continue to invest in improving our quality systems to provide even greater assurances to our customers.”

Editor's Details

Emma Cox
The Remarkable Group

Last updated on: 09/10/2012

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.